athenahealth PT Raised to $192.00 at Sterne Agee (ATHN)
Stock analysts at Sterne Agee raised their target price on shares of athenahealth (NASDAQ:ATHN) from $179.00 to $192.00 in a report issued on Friday, Analyst Ratings Network reports. Sterne Agee’s price target would indicate a potential upside of 10.39% from the company’s current price.
A number of other firms have also recently commented on ATHN. Analysts at Raymond James upgraded shares of athenahealth from an “outperform” rating to a “strong-buy” rating in a research note to investors on Friday, December 13th. They now have a $150.00 price target on the stock. Separately, analysts at Leerink Swann upgraded shares of athenahealth from a “market perform” rating to an “outperform” rating in a research note to investors on Friday, December 13th. They now have a $150.00 price target on the stock. Finally, analysts at ISI Group raised their price target on shares of athenahealth from $126.00 to $133.00 in a research note to investors on Friday, December 13th. They now have a “neutral” rating on the stock. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. athenahealth has a consensus rating of “Hold” and an average price target of $138.93.
athenahealth (NASDAQ:ATHN) traded up 25.06% on Friday, hitting $173.93. 3,333,294 shares of the company’s stock traded hands. athenahealth has a 52 week low of $82.01 and a 52 week high of $177.79. The stock’s 50-day moving average is $138.1 and its 200-day moving average is $124.. The company’s market cap is $6.464 billion.
athenahealth (NASDAQ:ATHN) last released its earnings data on Thursday, February 6th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.12. The company had revenue of $171.60 million for the quarter, compared to the consensus estimate of $168.39 million. During the same quarter in the previous year, the company posted $0.29 earnings per share. The company’s revenue for the quarter was up 47.5% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.04 earnings per share for the current fiscal year.
In other athenahealth news, SVP Daniel Orenstein sold 1,000 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $146.73, for a total value of $146,730.00. Following the completion of the transaction, the senior vice president now directly owns 31,262 shares in the company, valued at approximately $4,587,073. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.